Misa Iwatani

1.1k total citations
15 papers, 612 citations indexed

About

Misa Iwatani is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Misa Iwatani has authored 15 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Immunology and Allergy. Recurrent topics in Misa Iwatani's work include Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (5 papers). Misa Iwatani is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (5 papers). Misa Iwatani collaborates with scholars based in Japan, United States and Canada. Misa Iwatani's co-authors include Kunio Shiota, Satoshi Tanaka, Shintaro Yagi, Naka Hattori, Kohta Ikegami, Yuliya Kremenska, Shinsuke Araki, Toshiyuki Nomura, Risa Miyashita and Yusuke Nakayama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Misa Iwatani

14 papers receiving 595 citations

Peers

Countries citing papers authored by Misa Iwatani

Since Specialization

Citations

This map shows the geographic impact of Misa Iwatani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misa Iwatani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misa Iwatani more than expected).

Fields of papers citing papers by Misa Iwatani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misa Iwatani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misa Iwatani. The network helps show where Misa Iwatani may publish in the future.

Co-authorship network of co-authors of Misa Iwatani

This figure shows the co-authorship network connecting the top 25 collaborators of Misa Iwatani. A scholar is included among the top collaborators of Misa Iwatani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misa Iwatani. Misa Iwatani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Discovery of Rogocekib (CTX-712): A Potent and Selective CLK Inhibitor for Cancer Treatment 2025 ·ACS Medicinal Chemistry Letters ·Youichi Kawakita, (unknown), (unknown), Y. ITO, (unknown), Hiroshi Banno, Xin Liu, Koji Ono, (unknown), (unknown), Kenichi Iwai, Yukiko Yamamoto, Misa Iwatani, Noriko Uchiyama, (unknown), Akio Mizutani, Yoshihiko Satoh, Yasuyoshi Arikawa, Daisuke Morishita, Kenichiro Shimokawa	0
2	Design, synthesis, and structure–activity relationship of TAK-418 and its derivatives as a novel series of LSD1 inhibitors with lowered risk of hematological side effects 2022 ·European Journal of Medicinal Chemistry ·(unknown), Shigemitsu Matsumoto, Shinji Morimoto, Masaki Daini, (unknown), Satoru Matsuda, (unknown), Koji Murakami, Misa Iwatani, Hideyuki Oki, Shinji Iwasaki, (unknown), Yusuke Tominari, Haruhide Kimura, Mitsuhiro Ito	13
3	Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assays 2020 ·Biochemical and Biophysical Research Communications ·(unknown), Masahiro Nogami, Misa Iwatani, Toshihiro Imaeda, Masahiro Ito, Toshio Tanaka, Michiko Tawada, Satoshi Endo, Douglas R. Cary, Momoko Ohori, Yasuhiro Imaeda, Tomohiro Kawamoto, Samuel Aparício, Atsushi Nakanishi, Shinsuke Araki	10
4	T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice 2018 ·Neuropsychopharmacology ·Satoru Matsuda, (unknown), Hideyuki Oki, Shinji Morimoto, (unknown), S. Igaki, Yusuke Kamada, Shinji Iwasaki, (unknown), (unknown), (unknown), Takeshi Hirakawa, Misa Iwatani, Ken Tsuchida, Ryujiro Hara, Mitsuhiro Ito, Haruhide Kimura	38
5	Prolyl-tRNA synthetase inhibition promotes cell death in SK-MEL-2 cells through GCN2-ATF4 pathway activation 2017 ·Biochemical and Biophysical Research Communications ·Takeo Arita, Megumi Morimoto, Yukiko Yamamoto, Hitoshi Miyashita, Satoshi Kitazawa, Takaharu Hirayama, (unknown), Kazumasa Miyamoto, Ryutaro Adachi, Misa Iwatani, Takahito Hara	16
6	Discovery of selective ATP-competitive eIF4A3 inhibitors 2017 ·Bioorganic & Medicinal Chemistry ·Masahiro Ito, Misa Iwatani, Yusuke Kamada, Satoshi Sogabe, (unknown), Toshio Tanaka, Tomohiro Kawamoto, Samuel Aparício, Atsushi Nakanishi, Yasuhiro Imaeda	26
7	Discovery of spiro[indole-3,2′-pyrrolidin]-2(1H)-one based inhibitors targeting Brr2, a core component of the U5 snRNP 2017 ·Bioorganic & Medicinal Chemistry ·Masahiro Ito, Misa Iwatani, Takeshi Yamamoto, Toshio Tanaka, Tomohiro Kawamoto, Daisuke Morishita, Atsushi Nakanishi, Hironobu Maezaki	20
8	Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing 2015 ·PLoS ONE ·Shinsuke Araki, Ryo Dairiki, Yusuke Nakayama, Aiko Murai, Risa Miyashita, Misa Iwatani, Toshiyuki Nomura, Osamu Nakanishi	91
9	Structure-based discovery of cellular-active allosteric inhibitors of FAK 2013 ·Bioorganic & Medicinal Chemistry Letters ·Naoki Tomita, Yoko Hayashi, (unknown), (unknown), Yoshio Aramaki, Yoshihiro Matsushita, Misa Iwatani, Hidehisa Iwata, (unknown), (unknown), (unknown), R.J. Skene, David J. Hosfield, Hiroshi Miki, Tomohiro Kawamoto, Akira Hori, Atsuo Baba	45
10	Discovery and characterization of novel allosteric FAK inhibitors 2012 ·European Journal of Medicinal Chemistry ·Misa Iwatani, Hidehisa Iwata, (unknown), R.J. Skene, Naoki Tomita, Yoko Hayashi, Yoshio Aramaki, David J. Hosfield, Akira Hori, Atsuo Baba, Hiroshi Miki	42
11	Genome‐wide DNA methylation profile of tissue‐dependent and differentially methylated regions (T‐DMRs) residing in mouse pluripotent stem cells 2010 ·Genes to Cells ·Shinya Sato, Shintaro Yagi, Yoshikazu Arai, Keiji Hirabayashi, Naoko Hattori, Misa Iwatani, Keisuke Okita, Jun Ohgane, Satoshi Tanaka, Teruhiko Wakayama, Shinya Yamanaka, Kunio Shiota	26
12	Resistance to 5-aza-2'-deoxycytidine in Genic Regions Compared to Non-genic Repetitive Sequences 2010 ·Journal of Reproduction and Development ·(unknown), Misa Iwatani, Naoko Hattori, Satoshi Tanaka, Shintaro Yagi, Kunio Shiota	10
13	Establishment of trophoblast stem cell lines from somatic cell nuclear-transferred embryos 2009 ·Proceedings of the National Academy of Sciences ·Mayumi Oda, Satoshi Tanaka, Yukiko Yamazaki, Hiroshi Ohta, Misa Iwatani, Masako Suzuki, Jun Ohgane, Naka Hattori, Ryuzo Yanagimachi, Teruhiko Wakayama, Kunio Shiota	20
14	Genome‐wide and locus‐specific DNA hypomethylation in G9a deficient mouse embryonic stem cells 2006 ·Genes to Cells ·Kohta Ikegami, Misa Iwatani, Masako Suzuki, Makoto Tachibana, Yoichi Shinkai, Satoshi Tanaka, John M. Greally, Shintaro Yagi, Naka Hattori, Kunio Shiota	62
15	Dimethyl Sulfoxide Has an Impact on Epigenetic Profile in Mouse Embryoid Body 2006 ·Stem Cells ·Misa Iwatani, Kohta Ikegami, Yuliya Kremenska, Naka Hattori, Satoshi Tanaka, Shintaro Yagi, Kunio Shiota	193

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact